Table 5.
Days in hospital for acute myeloid leukemia (AML) patients responding to treatment with valproic acid, all-trans retinoic acid (ATRA) and low-dose cytarabine
| Patient | Overall survival (days) |
Days in hospital relative to the total number of days: |
|
|---|---|---|---|
| From start of therapy to death | For the last 28 days before death | ||
| CR1 |
296 |
59/ 296 |
0 |
| CR2 |
383 |
42/ 383 |
8 |
| SD1 |
102 |
18/ 102 |
14 |
| SD2 |
419 |
20/ 419 |
6 |
| SD3 |
171 |
54/ 171 |
4 |
| SD4 |
151 |
93/ 151 |
23 |
| SD5 |
239 |
80/ 239 |
18 |
| SD6 |
147 |
35/ 147 |
2 |
| SD7 |
132 |
41/ 132 |
4 |
| SD8 |
> 574 |
12/ > 574 |
Still alive and living at home |
| SD9 | > 141 | 12/ > 141 | Still alive and living at home |